Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): Increasing frequency of multiple resistance

Diagnostic Microbiology and Infectious Disease

Volumn 28, Issue 4, 1997, Pages 165-171

  Bogaerts, Jos ^a,b,d   Verhaegen, Jan ^c   Munyabikali, Jean Paul ^e   Mukantabana, Bernadette ^e   Lemmens, Paul ^c   Vandeven, Jos ^c   Vandepitte, Jos ^c  

^a Centre Hospitalier Universitaire de Kigali   (Rwanda)

^b BADC   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NORFLOXACIN; PIVMECILLINAM; QUINOLONE DERIVATIVE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DEMOCRATIC REPUBLIC CONGO; DYSENTERY; EPIDEMIC; HUMAN; NONHUMAN; PRIORITY JOURNAL; RWANDA; SEROTYPE; SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE; DYSENTERY, BACILLARY; HUMANS; MICROBIAL SENSITIVITY TESTS; RWANDA; SEROTYPING; SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SPECIES SPECIFICITY;

EID: 0030819622     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00072-2     Document Type: Article

References (32)

1. Ashkenazi S, May-Zahav M, Sulkes J, Zilberberg R, Samra Z (1995) Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 39:819-823.
2. Batungwanayo J, Taelman H, Bogaerts J, Clerinx J, Kagame A, Van Deun A, Morales I, Van Den Eynde J, Van de Perre P (1996) Impact of human immunodeficiency virus infection on tuberculosis in Kigali, Rwanda: one-year study of 377 consecutive cases. Int J Infect Dis 1:22-27.
3. Bennish M, Salam MA, Hossain MA, Myaux J, Khan EH, Chakraborty J, Henry F, Ronsmans C (1992a) Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis 14:1055-1060.
4. Bennish ML, Salam MA, Khan WA, Khan AM (1992b) Treatment of shigellosis: III. Comparison of one-or two dose ciprofloxacin with standard 5-day therapy. Ann Intern Med 117:727-734.
5. Bogaerts J, Vandepitte J, Mubiligi V, Habiyaremye I, Ghysels G (1982) Les Shigella et Salmonella à Butare (Rwanda) 1974-1980. Ann Soc Belge Méd Trop 62:353-359.
6. Bogaerts J, Bosmans E, Vandenbulcke L, Lemmens P, Lepage P, Vandepitte J, Ghysels G (1985) Shigella and Salmonella species from Kigali (Rwanda) (1976-1982). Ann Soc Belge Méd Trop 65:281-292.
7. Bosmans E, Engelen A, Van Ourti C, Vandepitte J, Ghysels G (1977) Les Shigella et Salmonella à Kigali (Rwanda). Ann Soc Belge Méd Trop 57:29-38.
8. Ebright JR, Moore EC, Sanborn WR, Schaberg DS, Kyle J, Ishida K (1984) Epidemic Shiga bacillus dysentery in Central Africa. Am J Trop Med Hyg 33:1192-1197.
9. Engels D, Madaras T, Nyandwi S, Murray J (1995) Epidemic dysentery caused by Shigella dysenteriae type 1: A sentinel site surveillance of antimicrobial resistance patterns in Burundi. WHO Bull 73:787-791.
10. Ewing WH (1986) Shigella. In Edwards and Ewing's Identification of Enterobacteriaceae. New York: Elsevier Science Publishing Co, pp 135-179.
11. Frost JA, Rowe B, Vandepitte J, Threlfall EJ (1981) Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae 1 in Central Africa. Lancet 2:1074-1076.
12. Frost JA, Rowe B, Vandepitte J (1982) Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae 1 from Zaire. Lancet 1:963.
13. Griffin PM, Tauxe RV, Redd SC, Puhr ND, Hargrett-Bean N, Blake PA (1989) Emergence of highly trimethoprim-sulfamethoxazole resistant Shigella in native American populations. An epidemiological study. Am J Epidemiol 129:1042-1050.
14. Habiyaremye I, Mutwewingabo A, Lemmens P, Ghysels P, Vandepitte J (1985) Les Shigella et Salmonella à Butare (Rwanda) 1981-1984. Ann Soc Belge Méd Trop 66:47-56.
15. Islam MS, Siddique AKM, Salam A, Akram K, Majumdar RN, Zaman K, Fronczak N, Laston S (1995) Microbiological investigation of diarrhea epidemics among Rwandan refugees in Zaire. Trans Royal Soc Trop Med Hyg 89:506.
16. Kabir I, Rahaman MM, Ahmed SM, Akhter SQ, Butler T (1984) Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob Agents Chemother 25:643-645.
17. Kelly MT, Brenner DJ, Framer III JJ (1985) Enterobacteriaceae. In Manual of Clinical Microbiology. Eds, EH Lennette, A Balows, WJ Hausler, HJ Shadomy. Washington, DC: American Society for Microbiology, pp 263-277.
18. Malengreau M (1984) Nalidixic acid in Shigella dysenteriae outbreaks. Lancet 2:172.
19. Malengreau M, Molima-Kaba, Gillieaux M, De Feyter M, Kyele-Duibone, Mukolo-Ndjolo (1987) Outbreak of Shigella dysentery in Eastern Zaire. Ann Soc Belge Méd Trop 67:173-178.
20. Mata LJ, Gangarosa EJ, Caceres A, Perera DR, Mejicanos ML (1970) Epidemic Shiga-bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J Infect Dis 122:170-180.
21. Mutwewingabo A, Mets T (1987). Increase in multiresistance of a Shigella dysenteriae type 1 strain in Rwanda. East Afr Med J 64:812-815.
22. National Committee for Clinical Laboratory Standards (1984) (NCCLS) Approved standard MS-A3. Villanova, PA, USA: NCCLS.
23. National Committee for Clinical Laboratory Standards (1993) (NCCLS) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard M7-A3. Villanova, PA, USA: NCCLS.
24. Olarte J, Filloy L, Gallindo E (1976) Resistance of Shigella dysenteriae type 1 to ampicillin and other antimicrobial agents: strains isolated during a dysentery outbreak in a hospital in Mexico City. J Infect Dis 133:572-575.
25. Ott D, Rogerie F (1987) Etude analytique d'une épidémie de dysentérie bacillaire au Rwanda. Aspects épidémiologiques et bactériologiques. Méd Trop 47:9-15.
26. Ries AA, Wells JG, Olivola D, et al (1994) Epidemic Shigella dysenteriae type 1 in Burundi: Panresistance and implications for prevention. J Infect Dis 169:1035-1041.
27. Rogerie F, Vimont-Vicary P (1986a) Etude bactériologique des shigelloses dans la région du Lac Kivu (Afrique Centrale). Evolution au cours des quinze dernières années (1968-1983). Bull Soc Pathol Exot 79:435-446.
28. Rogerie F, Ott D. Vandepitte J, Verbist L, Lemmens P, Habiyaremye I (1986b) Comparison of norfloxacin and nalidixic acid treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother 29:883-886.
29. Rogerie F, Vandepitte J, Lemmens P, Habiyaremye I, Bogaerts J, Vimont-Vicary P, Ott D (1987) La Shigellose au Nord-Rwanda 1982-1985. Ann Soc Belge Méd Trop 67: 173-178.
30. Vandepitte J (1982) Infections gastrointestinales dues à Shigella, Salmonella et autres entéropathogènes. In Santé et Maladies au Rwanda. Brussels, Belgium: Administration Générale de la Coopération au Développement, pp 275-293.
31. Vimont-Vicary P, Rogerie F (1985) Etude sur trois ans d'une épidémie de shigellose au Rwanda-Afrique Centrale. Problèmes de santé publique et aspects bactériologiques. Méd Trop 45:235-243.
32. World Health Organization (1978) Surveillance for the prevention and control of health hazards due to antibiotic-resistant enterobacteria. WHO Tech Rep Series 624.